BIRC3 and prostate carcinoma: Similar localization to c-IAP-1, c-IAP-2 and XIAP in PC3 cells was described by McEleny et al. [36] in in vitro studies, suggesting that IAP may be an important contribution to apoptotic resistance in patients with prostate cancer.